Psychedelic Stock Review

We're now up 325% in just Under a Year. Last "big" News was Receiving a Priority Original Abbreviated New Drug Application, for KETARX™ (Ketamine)...

Psycheceutical’s Psychedelic Experience, a Safer More Viable Choice in Getting Treated. Imagine the benefits of psychedelics, without hallucinating! Our Favorite small Psychedelic company Psycheceutical Bioscience is using...

Conference call to discuss CYB003 interim results today, November 1, 2023 at 11:00 a.m. ET Cybin Announces Unprecedented Positive Phase 2 Interim Data for CYB003...

RELATED: Matthew Perry Reveals he Spent About $9M Trying to get Sober. Psychedelics CURED My Alcoholism—News Anchor Jon Kostakopoulos / Apollo Pact CEO https://youtu.be/ghqY7s6UweU?si=-a2tuAGflKfLKI_j https://youtu.be/fZzJB_UJ1X8?si=CsjSUacJ1qItKVyN Participant On Life-Changing Sobriety...

Amazing New Technologies Keep Popping up. We love when this happens during Sector Bear Markets, which Psychedelics have clearly been in. Amazing technology can be...

“The only legitimate addiction interrupter capable of breaking a heroin, meth, opiate, or alcohol addiction in a single 12-hour session.” Known as the “Psychedelic Concierge...

Steve Cohen from Point 72, Acquires 18,950,000 Shares of Cybin. Here's the filing, end of transmission. As we have nothing else to add. AKA...

A startup’s psychedelic delivery tech is grabbing attention. Will pharma listen? PharmaVoice Psycheceutical is developing a back-of-the-neck topical treatment for ketamine but believes the delivery...

Transaction led by healthcare specialist investors, TCGX and Aisling Capital $125 million financing upfront with up to an additional $160 million tied to exercise of...

Cohen Psychedelic Research & Health Initiative Cohen Foundation Awards $5 Million for MDMA Therapy Approval Millions of Americans suffer from depression, anxiety, addiction, post-traumatic stress disorder...